dedicated software platform for multimodal image analysis mim 6.7.0 (MIM Software Inc)
90
Structured Review
MIM Software Inc
dedicated software platform for multimodal image analysis mim 6.7.0
Dedicated Software Platform For Multimodal Image Analysis Mim 6.7.0, supplied by MIM Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dedicated+software+platform+for+multimodal+image+analysis+mim+6%2E7%2E0/imaging+software+mim+mim+6+5/pm34374802-63-37-42
Average 90 stars, based on 1 article reviews
Dedicated Software Platform For Multimodal Image Analysis Mim 6.7.0, supplied by MIM Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dedicated+software+platform+for+multimodal+image+analysis+mim+6%2E7%2E0/imaging+software+mim+mim+6+5/pm34374802-63-37-42
Average 90 stars, based on 1 article reviews
dedicated software platform for multimodal image analysis mim 6.7.0 - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Positron Emission Tomography:Article Title: Prospective comparison of simultaneous [ 68 Ga]Ga-PSMA-11 PET/MR versus PET/CT in patients with biochemically recurrent prostate cancer. Article Snippet: Objectives PSMA-PET has become the PET technique of choice to localise the site of biochemically recurrent prostate cancer (PCa).. With hybrid PET/MRI, the advantages of MRI are added to molecular characteristic of PET.. The aim of this study was to investigate the incremental value of PET/MR versus PET/CT in patients with biochemically recurrent PCa by head-to-head comparison. Software:Article Title: Prospective comparison of simultaneous [ 68 Ga]Ga-PSMA-11 PET/MR versus PET/CT in patients with biochemically recurrent prostate cancer. Article Snippet: Objectives PSMA-PET has become the PET technique of choice to localise the site of biochemically recurrent prostate cancer (PCa).. With hybrid PET/MRI, the advantages of MRI are added to molecular characteristic of PET.. The aim of this study was to investigate the incremental value of PET/MR versus PET/CT in patients with biochemically recurrent PCa by head-to-head comparison. |